Trial intelligence / Profile preview

Gabapentin for prevention of postoperative nausea and vomiting in burn surgery patients

IRCT2016100230072N2Phase 3Completed

Sponsor
Anesthesia Research Center
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin in postoperative nausea and vomiting (PONV), sponsored by Anesthesia Research Center. Started Aug 2016; status: completed.

02

Drugs

gabapentin
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT2016100230072N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016100230072N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call